Company / Interest Expense per Share
Haemonetics Interest Expense per Share History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.71
FY2024
5-year range
$0.11 / $0.71
FY2020-FY2024
Trend
+87.6%
vs FY2023
Sector context
#25 of 40
Health Care
What the data says
At $0.71, Haemonetics's interest expense per share ranks #16 of 40 in the Health Care sector. Interest Expense per Share has increased for 3 consecutive years, from $0.11 in FY2021 to $0.71 in FY2024.
Based on SEC 10-K filings.
0.71 in FY2024 with a 5-year CAGR of +22.3%.
Increased from $0.25 to $0.71 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +84.7%
- 5-Year CAGR
- +22.3%
- 10-Year CAGR
- -
Sector benchmark
#16 of 40 in Health CareTop 38% of 40This company $0.71 Sector average $1.56
▼
-54.5% below sector average
Key checks
Key Insights
- Haemonetics's interest expense per share has grown for 3 consecutive years.
- In FY2024, interest expense per share increased 87.6% year-over-year.
- Ranks #25 out of 40 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.71 | +87.6% |
| FY2023 | $0.38 | +50.1% |
| FY2022 | $0.25 | +123.8% |
| FY2021 | $0.11 | -38.4% |
| FY2020 | $0.18 | -29.7% |
| FY2019 | $0.26 | +8.1% |
| FY2018 | $0.24 | +59.5% |
| FY2017 | $0.15 | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026